Sun Pharma And Ranbaxy Laboratories

Rediff.com » News » Sun Pharma And Ranbaxy Laboratories

News for Sun Pharma And Ranbaxy Laboratories

Business

Sun Pharma-Ranbaxy deal may come under Sebi lens

The capital markets regulator, Securities and Exchange Board of India, is likely to begin a preliminary inquiry into the $4-billion merger deal between pharma giants Sun Pharmaceutical and Ranbaxy......

Maintain status-quo on Sun Pharma-Ranbaxy merger: HC to bourses

In a setback to Sun Pharma-Ranbaxy merger process, Andhra Pradesh High Court has issued orders to Bombay Stock Exchange and National Stock Exchange to maintain interim status quo on the......

Clearances for Sun-Ranbaxy merger may be delayed

Sun Pharma and Ranbaxy Laboratories might take longer than usual to secure all regulatory clearances for their proposed merger, sources said. The merger, announced on April 6, is being studied by......

Ranbaxy merger: Sun Pharma readies new leadership team

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the......

Sun Pharma gets US trade regulator nod for Ranbaxy deal

The US Federal Trade Commission (FTC) has completed its review of the proposed $4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under......

Rediff News

Sun Pharma And Ranbaxy Laboratories

News for Sun Pharma And Ranbaxy Laboratories

Sun Pharma-Ranbaxy deal may come under Sebi lens

Maintain status-quo on Sun Pharma-Ranbaxy merger: HC to bourses

Clearances for Sun-Ranbaxy merger may be delayed

Ranbaxy merger: Sun Pharma readies new leadership team

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS